Latest filing published 21 Apr 2022 for Novo Integrated Sciences, Inc., €9,660.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -95.1%Entry US$22.00 · Close at T+365 US$1.07
- -79.7%Entry US$63.70 · Close at T+365 US$12.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert Letterio Oliva: trading record in brief
All filings by Robert Letterio Oliva on record concern Novo Integrated Sciences, Inc., in the capacity of board member. We count 6 filings; the first trade dates from 22 February 2021 and the latest from 20 April 2022.
The open-market record is one-sided, with 6 purchases worth €77k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2022, the count stands at 3 purchases and no sales.
The median purchase comes to €9,983. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -14.1%. This is a record of the past, not a forecast.
The latest filing, published on 21 April 2022, reports an open-market purchase of €9,660 in Novo Integrated Sciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Letterio Oliva
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,700 shares@ US$2.230.0% of flowCommon StockSEC:0001493152-22-010621:1Canonical exit: 19 Jul 2022 (T+90)
- 300 shares@ US$2.250.0% of flowCommon StockSEC:0001493152-22-010621:2Canonical exit: 19 Jul 2022 (T+90)
- 5,000 shares@ US$2.225100.0% of flowCommon StockSEC:0001493152-22-010621:0Canonical exit: 18 Jul 2022 (T+90)
- 13,000 shares@ US$2.12Common StockSEC:0001493152-21-009571:0Canonical exit: 20 Jul 2021 (T+90)
- 9,355 shares@ US$4.310.0% of flowCommon StockSEC:0001493152-21-004650:0Canonical exit: 23 May 2021 (T+90)
- 200 shares@ US$4.45Common StockSEC:0001493152-21-004650:1Canonical exit: 24 May 2021 (T+90)
6 of 6 declarations